Csaba Hetényi

Dr. Csaba Hetényi

Department of Pharmacology and Pharmacotherapy, Medical School, University of Pecs, Szigeti ut 12, Pecs, Hungary
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MKMihály Kovács
Mihály Kovács
JTJudit Tóth
Judit Tóth
Csaba HetényiCsaba Hetényi
Csaba Hetényi
AMAndrás Málnási-Csizmadia
András Málnási-Csizmadia
JSJames R. Sellers
James R. Sellers
Blebbistatin is a recently discovered small molecule inhibitor showing high affinity and selectivity toward myosin II. Here we report a detailed investigation of its mechanism of inhibition. Blebbistatin does not compete with nucleotide binding to the skeletal muscle myosin subfragment-1. The inhibitor preferentially binds to the ATPase intermediate with ADP and phosphate bound at the active site, and it slows down phosphate release. Blebbistatin interferes neither with binding of myosin to actin nor with ATP-induced actomyosin dissociation. Instead, it blocks the myosin heads in a products complex with low actin affinity. Blind docking molecular simulations indicate that the productive blebbistatin-binding site of the myosin head is within the aqueous cavity between the nucleotide pocket and the cleft of the actin-binding interface. The property that blebbistatin blocks myosin II in an actin-detached state makes the compound useful both in muscle physiology and in exploring the cellular function of cytoplasmic myosin II isoforms, whereas the stabilization of a specific myosin intermediate confers a great potential in structural studies.

1 July 2002 in Protein Science
Verified
Journal Article
Closed access
PDF file
Csaba HetényiCsaba Hetényi
Csaba Hetényi
DSDavid van der Spoel
David van der Spoel

31 January 2006 in FEBS Letters
Verified
Journal Article
Closed access
Csaba HetényiCsaba Hetényi
Csaba Hetényi
DSDavid van der Spoel
David van der Spoel

1 April 2021 in Current Opinion in Structural Biology
Verified
Journal Article
Open access
BZBalázs Zoltán Zsidó
Balázs Zoltán Zsidó
Csaba HetényiCsaba Hetényi
Csaba Hetényi

16 March 2011 in Protein Science
Verified
Journal Article
Open access
PDF file
Csaba HetényiCsaba Hetényi
Csaba Hetényi
DSDavid van der Spoel
David van der Spoel
Location of functional binding pockets of bioactive ligands on protein molecules is essential in structural genomics and drug design projects. If the experimental determination of ligand‐protein complex structures is complicated, blind docking (BD) and pocket search (PS) calculations can help in the prediction of atomic resolution binding mode and the location of the pocket of a ligand on the entire protein surface. Whereas the number of successful predictions by these methods is increasing even for the complicated cases of exosites or allosteric binding sites, their reliability has not been fully established. For a critical assessment of reliability, we use a set of ligand‐protein complexes, which were found to be problematic in previous studies. The robustness of BD and PS methods is addressed in terms of success of the selection of truly functional pockets from among the many putative ones identified on the surfaces of ligand‐bound and ligand‐free (holo and apo) protein forms. Issues related to BD such as effect of hydration, existence of multiple pockets, and competition of subsidiary ligands are considered. Practical cases of PS are discussed, categorized and strategies are recommended for handling the different situations. PS can be used in conjunction with BD, as we find that a consensus approach combining the techniques improves predictive power.

1 July 2001 in Chromatographia
Verified
Journal Article
Closed access
PDF file
DTD. Tong
D. Tong
Csaba HetényiCsaba Hetényi
Csaba Hetényi
ZBZs. Bikádi
Zs. Bikádi
JGJ. -P. Gao
J. -P. Gao
SHS. Hjertén
S. Hjertén